Ophthalmic studies rely on complex tests and assessments to meet clinical study endpoints.
Each test may be time-consuming to administer, assess, and interpret. Consequently, it is
important not to overcrowd a study with unnecessary assessments. Choosing endpoints
that are clinically relevant is increasingly important in bringing new therapies to market
more quickly. This paper provides a brief overview of some common endpoints in ophthalmology research, and issues to take into account when considering endpoints for ophthalmic studies.
Download to find out more.